Q. Pan

发表

Phase I study of pegylated liposomal doxorubicin and cisplatin in patients with advanced osteosarcoma

Jing-jing Zhao, Qiu-zhong Pan, D. Weng, 2022, Cancer Chemotherapy and Pharmacology.

SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway

Jing-jing Zhao, Qi-jing Wang, Qiu-zhong Pan, 2022, International journal of biological sciences.

Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma

Min Li, J. Xia, Chao Yang, 2020, Journal of Hematology & Oncology.

CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype

Yue Li, J. Xia, Libing Song, 2022, Journal for ImmunoTherapy of Cancer.

Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin

Jing-jing Zhao, Qi-jing Wang, Qiu-zhong Pan, 2021, Cell Death & Disease.

Decreased Expression of the ARID1A Gene Is Associated with Poor Prognosis in Primary Gastric Cancer

K. Pan, Dan-dan Wang, Lin Lv, 2012, PloS one.

A novel pathogenic germline mutation in the adenomatous polyposis coli gene in a Chinese family with familial adenomatous coli

Y. Zeng, K. Pan, Shan-shan Jiang, 2015, Oncotarget.

Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma

Lujun Shen, Yizhuo Zhang, X. Niu, 2021, Journal for ImmunoTherapy of Cancer.

Annexin A3 upregulates the infiltrated neutrophil-lymphocyte ratio to remodel the immune microenvironment in hepatocellular carcinoma.

Min Li, J. Xia, Ming-Yuan Chen, 2020, International immunopharmacology.

CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma

Jing-jing Zhao, Qi-jing Wang, Qiu-zhong Pan, 2022, Cell Death & Disease.

Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma

Shan-shan Jiang, J. Xia, Ying Wu, 2015, Oncotarget.

Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma

J. Xia, Yan Tang, D. Weng, 2020, British Journal of Cancer.

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

Yaojun Zhang, K. Pan, Shan-shan Jiang, 2014, Journal of Translational Medicine.

Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma

Shan-shan Jiang, J. Xia, Yan Tang, 2015, Oncotarget.

Decreased expression of V‐set and immunoglobulin domain containing 1 (VSIG1) is associated with poor prognosis in primary gastric cancer

Jing-jing Zhao, Qi-jing Wang, K. Pan, 2012, Journal of surgical oncology.

Large-scale analyses identify a cluster of novel long noncoding RNAs as potential competitive endogenous RNAs in progression of hepatocellular carcinoma

J. Xia, Yan Tang, D. Weng, 2019, Aging.

The Prognostic Value of Tumor-Infiltrating Neutrophils in Gastric Adenocarcinoma after Resection

Jing-jing Zhao, K. Pan, Dan-dan Wang, 2012, PloS one.

Dendritic‐cell‐based immunotherapy evokes potent anti‐tumor immune responses in CD105+ human renal cancer stem cells

A. Chang, M. Wicha, Y. Zeng, 2017, Molecular carcinogenesis.

Immunization-based scores as independent prognostic predictors in soft tissue sarcoma patients

Shan-shan Jiang, J. Xia, Yuan-Fang Li, 2017, Journal of Cancer.

Expression and clinical significance of cytochrome c oxidase subunit IV in colorectal cancer patients

Yibing Chen, Shanshan Jiang, Kun Zhang, 2016, Archives of medical science : AMS.

Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma

K. Pan, Dan-dan Wang, Shan-shan Jiang, 2013, Cancer Immunology, Immunotherapy.

The efficacy and safety of the combination of axitinib and pembrolizumab‐activated autologous DC‐CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study

F. Zhou, J. Xia, P. Dong, 2021, Clinical & translational immunology.

The efﬁcacy and safety of the combination of axitinib and pembrolizumab-activated autologous DC-CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study

Yan Ding, Jing-jing Zhao, Qi-jing Wang, 2021 .

IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma

Chun-yu Huang, J. Xia, Yan Tang, 2018, Oncoimmunology.

Identification of LZAP as a New Candidate Tumor Suppressor in Hepatocellular Carcinoma

Minshan Chen, K. Pan, Dan-dan Wang, 2011, PloS one.

Cancer‐Associated Fibroblast‐Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression

Yaojun Zhang, Jing-jing Zhao, Qi-jing Wang, 2021, Hepatology.

Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer

Jing-jing Zhao, Qiu-zhong Pan, J. Xia, 2017, Chinese journal of cancer.

Retrospective analysis of the efficacy of cytokine‐induced killer cell immunotherapy combined with first‐line chemotherapy in patients with metastatic colorectal cancer

J. Xia, Yan Tang, D. Weng, 2020, Clinical & translational immunology.

Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma

K. Pan, Shan-shan Jiang, J. Xia, 2016, Oncotarget.

Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis.

K. Pan, J. Xia, D. Weng, 2016, Oncotarget.

Annexin A3 as a Potential Target for Immunotherapy of Liver Cancer Stem‐Like Cells

Yan Tang, Shan Jiang, K. Pan, 2015, Stem cells.

PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma

Y. Zeng, K. Pan, Shan-shan Jiang, 2016, Oncoimmunology.

Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer

Jing-jing Zhao, K. Pan, Qiu-zhong Pan, 2014, Medical Oncology.

A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma

A. Chang, Jiang Li, Zhongguo Zhou, 2015, Oncotarget.

Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer

Y. Zeng, Jing-jing Zhao, Qi-jing Wang, 2015, Oncoimmunology.

Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma

J. Xia, Peng Wang, Yan Tang, 2018, Cancer management and research.

New nomograms to predict overall and cancer‐specific survival of angiosarcoma

D. Weng, Xing Zhang, R. Peng, 2021, Cancer medicine.

Clinical Effect of Adjuvant Cytokine-Induced Killer Cells Immunotherapy in Patients with Stage II-IVB Nasopharyngeal Carcinoma after Chemoradiotherapy: A propensity score analysis

Jing-jing Zhao, Qiu-zhong Pan, J. Xia, 2018, Journal of Cancer.

Chimeric antigen receptor‐modified T‐cell therapy for platelet‐derived growth factor receptor α‐positive rhabdomyosarcoma

Jing-jing Zhao, Qiu-zhong Pan, Liping Xu, 2020, Cancer.

Severe delayed pulmonary toxicity following PD‐L1–specific CAR‐T cell therapy for non‐small cell lung cancer

J. Xia, Li Zhang, W. Fang, 2020, Clinical & translational immunology.

Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells

K. Pan, Dan-dan Wang, Shan-shan Jiang, 2014, Scientific Reports.

Safety and activity of PD-1 blockade-activated DC-CIK cells in patients with advanced solid tumors

F. Zhou, Zhi‐Ling Zhang, Chuan-miao Xie, 2017, Oncoimmunology.

Overexpression of WWP1 Promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma

K. Pan, Shan-shan Jiang, J. Xia, 2015, Oncotarget.

Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma

K. Pan, Dan-dan Wang, Shan-shan Jiang, 2015, Molecular carcinogenesis.

A Nomogram for Predicting the Benefit of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Hepatocellular Carcinoma

A. Chang, M. Wicha, Y. Zeng, 2015, Scientific Reports.

Weekly versus triweekly cisplatin plus intensity-modulated radiotherapy in locally advanced nasopharyngeal carcinoma: A propensity score analysis with a large cohort

J. Xia, R. You, Yan Tang, 2018, Journal of Cancer.

Decreased Expression of the FOXO3a Gene Is Associated with Poor Prognosis in Primary Gastric Adenocarcinoma Patients

Xiaobo Yang, Jing-jing Zhao, Chun-yu Huang, 2013, PloS one.

PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer

J. Xia, Yan Tang, D. Weng, 2019, Journal of Immunotherapy for Cancer.

The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma

Minshan Chen, Yaojun Zhang, K. Pan, 2016, Journal of Cancer.

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma

Yibing Chen, W. Du, J. Xia, 2018, BMC Cancer.

Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection

J. Xia, Yan Tang, D. Weng, 2020, Oncoimmunology.

High expression level of T-box transcription factor 5 predicts unfavorable survival in stage I and II gastric adenocarcinoma

Jing-jing Zhao, Chun-yu Huang, Dan-dan Wang, 2015, Oncology letters.

Using reverse transcription-quantitative polymerase chain reaction, the TBX5 mRNA expression levels in 30 pairs of surgically resected healthy gastric tissues and early stage

Jing-jing Zhao, Chun-yu Huang, Dan-dan Wang, 2015 .

Decreased expression of TRIM3 is associated with poor prognosis in patients with primary hepatocellular carcinoma

Jing-jing Zhao, Qiu-zhong Pan, J. Xia, 2014, Medical Oncology.

IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma

J. Xia, Yan Tang, D. Weng, 2019, Cancer management and research.

CMAR_A_200627 6691..6702

Jing-jing Zhao, Qiu-zhong Pan, J. Xia, 2019 .

PD-L1 expression patterns in tumour cells and their association with CD8+ tumour infiltrating lymphocytes in clear cell renal cell carcinoma

Min Li, J. Xia, M. Cai, 2019, Journal of Cancer.

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma

Yibing Chen, W. Du, J. Xia, 2018, BMC Cancer.

TES functions as a Mena-dependent tumor suppressor in gastric cancer carcinogenesis and metastasis

K. Pan, Dan-dan Wang, Lin Lv, 2019, Cancer communications.

IL-17A Promotes Immune Cell Recruitment in Human Esophageal Cancers and the Infiltrating Dendritic Cells Represent a Positive Prognostic Marker for Patient Survival

A. Chang, Jing-jing Zhao, K. Pan, 2013, Journal of immunotherapy.

BMP9‐induced vascular normalisation improves the efficacy of immunotherapy against hepatitis B virus‐associated hepatocellular carcinoma

Yaojun Zhang, J. Xia, Jinfeng Xu, 2023, Clinical and translational medicine.

OK‐432 synergizes with IFN‐γ to confer dendritic cells with enhanced antitumor immunity

A. Chang, Jing-jing Zhao, K. Pan, 2014, Immunology and cell biology.

Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer

J. Xia, Yan Tang, D. Weng, 2022, Frontiers in Immunology.

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

Yaojun Zhang, K. Pan, Lin Lv, 2014, Journal of Translational Medicine.

CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma

J. Xia, Yan Tang, D. Weng, 2020, Cancer Immunology, Immunotherapy.

Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A∗02:01 patients with advanced soft tissue sarcoma

Jing Yang, J. Lau, Jiewen Chen, 2023, Cell Reports Medicine.

Lenvatinib improves anti-PD-1 therapeutic efficacy by promoting vascular normalization via the NRP-1-PDGFRβ complex in hepatocellular carcinoma

J. Xia, Yan Tang, D. Weng, 2023, Frontiers in immunology.

Expression and prognostic role of ubiquitination factor E4B in primary hepatocellular carcinoma

K. Pan, Dan-dan Wang, Shan-shan Jiang, 2016, Molecular carcinogenesis.

OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis

Jing-jing Zhao, Qi-jing Wang, Qiu-zhong Pan, 2022, Journal of Experimental & Clinical Cancer Research.

Targeted delivery of a PD-1-blocking scFv by CD133-specific CAR-T cells using nonviral Sleeping Beauty transposition shows enhanced antitumour efficacy for advanced hepatocellular carcinoma

J. Xia, Zhongqiu Liu, Yan Tang, 2023, BMC Medicine.

XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial

Li Zhou, D. Zhang, Q. Pan, 2024, Signal transduction and targeted therapy.

Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis

K. Pan, Shan-shan Jiang, J. Xia, 2016, Oncotarget.